Jennifer L. Good, President & CEO: Trevi Therapeutics TRVI Sell · Filed 24/05/14

Trade details

Type: Insider sale
Amount: $13,276.2
Shares · price: 4,578 sh · $2.90 a share
Held after: 213,313 sh
Stock: Trevi Therapeutics TRVI
Person: Jennifer L. GoodPresident & CEO
Trade date: 24/05/10
Filed: 24/05/14
Days to filing: 4 days

Sold 2.1% of holdings

Share of holding sold: 2.1%

Trevi Therapeutics trades, last 26 weeks

What else happened in Trevi Therapeutics around then

Filed or reported within 30 days of the trade day · 24/04/10~24/06/09

Jennifer L. Good's recent trades

Jennifer L. GoodPresident & CEO
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$34.6K
5,263 sh
$34.6K
Filed 25/03/25
Traded 25/03/21
Jennifer L. GoodOfficer
Planned saleTrevi Therapeutics
Planned sale
Trevi Therapeutics
TRVI
$34.6K
5,263 sh
$34.6K
Filed 25/03/21
Traded 25/03/21
Jennifer L. GoodDirector
Sell10b5-1 planRhythm Pharmaceuticals
Sell10b5-1 plan
Rhythm Pharmaceuticals
RYTM
$1.7M
31,751 sh
$1.7M
Filed 24/09/19
Traded 24/09/17
Jennifer L. GoodDirector
Sell10b5-1 planRhythm Pharmaceuticals
Sell10b5-1 plan
Rhythm Pharmaceuticals
RYTM
$1.9M
37,241 sh
$1.9M
Filed 24/09/11
Traded 24/09/09
Jennifer L. GoodPresident & CEO
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$12.8K
4,219 sh
$12.8K
Filed 24/09/09
Traded 24/09/06